1Reveille JD, Rahman P, Sandoval DM, et al. Ixekizumab improves signs, symptoms, and quality of life of ankylosing spondyloarthritis in patients irrespective of HLA-B27 status: pooled results from the COAST-V and COAST-W trials. Poster presented at: European League Against Rheumatism Virtual Congress; June 2-5, 2021.